These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9111223)

  • 1. Oxidation-dependent inactivation of aryl sulfotransferase IV by primary N-hydroxy arylamines during in vitro assays.
    King RS; Duffel MW
    Carcinogenesis; 1997 Apr; 18(4):843-9. PubMed ID: 9111223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function modeling of the interactions of N-alkyl-N-hydroxyanilines with rat hepatic aryl sulfotransferase IV.
    King RS; Sharma V; Pedersen LC; Kakuta Y; Negishi M; Duffel MW
    Chem Res Toxicol; 2000 Dec; 13(12):1251-8. PubMed ID: 11123966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular specificity of aryl sulfotransferase IV (tyrosine-ester sulfotransferase) for xenobiotic substrates and inhibitors.
    Duffel MW
    Chem Biol Interact; 1994 Jun; 92(1-3):3-14. PubMed ID: 8033263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s).
    Chou HC; Lang NP; Kadlubar FF
    Cancer Res; 1995 Feb; 55(3):525-9. PubMed ID: 7834621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of aryl sulfotransferase by carboxylic acids.
    Rao SI; Duffel MW
    Drug Metab Dispos; 1991; 19(2):543-5. PubMed ID: 1676667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reaction product inactivation of aryl sulfotransferase IV following electrophilic substitution by the sulfuric acid ester of N-hydroxy-2-acetylaminofluorene.
    Ringer DP; Norton TR; Self RR
    Carcinogenesis; 1992 Jan; 13(1):107-12. PubMed ID: 1733562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation and detoxication of carcinogenic arylamines by sulfation.
    Yamazoe Y; Nagata K; Ozawa S; Gong DW; Kato R
    Princess Takamatsu Symp; 1995; 23():154-62. PubMed ID: 8844806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfation of hydroxylamines and hydroxamic acids in liver cytosol from male and female rats and purified aryl sulfotransferase IV.
    Gilissen RA; Ringer DP; Stavenuiter HJ; Mulder GJ; Meerman JH
    Carcinogenesis; 1992 Oct; 13(10):1699-703. PubMed ID: 1423828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Acetylaminofluorene-mediated alteration in the level of liver arylsulfotransferase IV during rat hepatocarcinogenesis.
    Ringer DP; Norton TR; Howell BA
    Cancer Res; 1990 Sep; 50(17):5301-7. PubMed ID: 2386938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-catalyzed irreversible inactivation of rat hepatic aryl sulfotransferase IV by N-hydroxy-2-acetylaminofluorene.
    Mangold BL; Erickson J; Lohr C; McCann DJ; Mangold JB
    Carcinogenesis; 1990 Sep; 11(9):1563-7. PubMed ID: 2401045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic metabolism of N-hydroxy-N-methyl-4-aminoazobenzene and other N-hydroxy arylamines to reactive sulfuric acid esters.
    Kadlubar FF; Miller JA; Miller EC
    Cancer Res; 1976 Jul; 36(7 PT 1):2350-9. PubMed ID: 819129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic N-oxidation of carcinogenic arylamines in relation to nitrogen charge density and oxidation potential.
    Kadlubar FF; Fu PP; Jung H; Shaikh AU; Beland FA
    Environ Health Perspect; 1990 Jul; 87():233-6. PubMed ID: 2269230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfation of di- and tricyclic phenols by rat liver aryl sulfotransferase isozymes.
    Parker MH; McCann DJ; Mangold JB
    Arch Biochem Biophys; 1994 May; 310(2):325-31. PubMed ID: 8179315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens.
    Banoglu E
    Curr Drug Metab; 2000 Jul; 1(1):1-30. PubMed ID: 11467078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometric investigation of the mechanism of inactivation of hamster arylamine N-acetyltransferase 1 by N-hydroxy-2-acetylaminofluorene.
    Guo Z; Wagner CR; Hanna PE
    Chem Res Toxicol; 2004 Mar; 17(3):275-86. PubMed ID: 15025497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases.
    Flammang TJ; Kadlubar FF
    Carcinogenesis; 1986 Jun; 7(6):919-26. PubMed ID: 3708755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of cytochrome P450 1A2-mediated formation of N-hydroxy arylamines and heterocyclic amines and their reaction with guanyl residues.
    Guengerich FP; Humphreys WG; Yun CH; Hammons GJ; Kadlubar FF; Seto Y; Okazaki O; Martin MV
    Princess Takamatsu Symp; 1995; 23():78-84. PubMed ID: 8844798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic acetylation and sulfation of N-hydroxyarylamines in bacteria and rat livers.
    Yamazoe Y; Abu-Zeid M; Gong DW; Staiano N; Kato R
    Carcinogenesis; 1989 Sep; 10(9):1675-9. PubMed ID: 2670304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of hepatic mRNA translation activity and specific expression of arylsulfotransferase IV during acetylaminofluorene-induced rat hepatocarcinogenesis.
    Yerokun T; Norton TR; Howell B; Ringer DP
    Cancer Res; 1991 Jan; 51(2):504-9. PubMed ID: 1670761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetyltransferase and sulfotransferase which activate mutagens and carcinogens through O-esterification mechanisms.
    Yamazoe Y; Abu-Zeid M; Gong DW; Ozawa S; Nagata K; Kato R
    Princess Takamatsu Symp; 1990; 21():109-17. PubMed ID: 2134670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.